ライフサイエンスコーパス: chlorhexidine

1 were analyzed (164 soap and water versus 161 chlorhexidine).

2 ggested a lack of resistance to mupirocin or chlorhexidine.

3 se the ocular safety and efficacy of aqueous chlorhexidine.

4 aily bathing of critically ill patients with chlorhexidine.

5 ents (9.6%) met the definition of allergy to chlorhexidine.

6 athogens than did clinical concentrations of chlorhexidine.

7 actions, 9.6% were diagnosed with allergy to chlorhexidine.

8 acter baylyi rendered it more susceptible to chlorhexidine.

9 t and specific interactions between AceI and chlorhexidine.

10 stance and transport, was still able to bind chlorhexidine.

11 le to mediate the energy-dependent efflux of chlorhexidine.

12 ed in significant increases in resistance to chlorhexidine.

13 rred in 7 patients, were mild and related to chlorhexidine.

14 matitis rate was 1.1% with and 0.29% without chlorhexidine.

15 to compare antiplaque efficacy in vivo with chlorhexidine.

16 reased after oral rinsing with antibacterial chlorhexidine.

17 cally active: clotrimazole, flunarizine, and chlorhexidine.

18 mvR also have an increased susceptibility to chlorhexidine.

19 nal specialists who exclusively used aqueous chlorhexidine 0.05% or 0.1% for prophylaxis of infective

20 d panel; many failed to screen all cases for chlorhexidine 19/44 (43%) or latex 21/44 (48%)], staffin

21 contaminated disks were burnished with 0.12% chlorhexidine, 20% citric acid, 24% EDTA/1.5% NaOCl, or

22 he following: NMBA (35%), antibiotics (46%), chlorhexidine (8%), patent blue dye (8%) and others (8%)

23 ional coating on titanium surfaces releasing chlorhexidine, a well-known antimicrobial agent used in

24 rt protein AceI, which confers resistance to chlorhexidine, a widely used antiseptic.

25 han abolishing the function of SmvR, as with chlorhexidine adaptation.

26 in overall SSI rate between IPA (18.7%) and chlorhexidine-alcohol (15.9%) was 2.8% (P = 0.30).

27 were enrolled; 572 patients were assigned to chlorhexidine-alcohol and 575 to iodine-alcohol.

28 omparing iodine povacrylex-alcohol (IPA) and chlorhexidine-alcohol for elective, clean-contaminated c

29 The use of chlorhexidine-alcohol for preoperative skin antisepsis r

30 olled trial, we evaluated whether the use of chlorhexidine-alcohol for preoperative skin antisepsis w

31 cial surgical-site infection was 3.0% in the chlorhexidine-alcohol group and 4.9% in the iodine-alcoh

32 A total of 849 subjects (409 in the chlorhexidine-alcohol group and 440 in the povidone-iodi

33 n was diagnosed in 23 patients (4.0%) in the chlorhexidine-alcohol group and in 42 (7.3%) in the iodi

34 ite infection was significantly lower in the chlorhexidine-alcohol group than in the povidone-iodine

35 esized that preoperative skin cleansing with chlorhexidine-alcohol is more protective against infecti

36 ean delivery to skin preparation with either chlorhexidine-alcohol or iodine-alcohol.

37 to preoperative skin preparation with either chlorhexidine-alcohol scrub or povidone-iodine scrub and

38 Chlorhexidine-alcohol was significantly more protective

39 he intent to treat analysis (396 IPA and 392 chlorhexidine-alcohol).

40 ity for overall SSI prevention compared with chlorhexidine-alcohol.

41 aims were to estimate (i) the prevalence of chlorhexidine allergy in perioperative allergy and (ii)

42 Chlorhexidine allergy was post hoc defined as a relevant

43 Using our definition of chlorhexidine allergy, the highest combined estimated se

44 ity and sensitivity for diagnostic tests for chlorhexidine allergy.

45 were 25 (<1%) adverse events, all involving chlorhexidine, among 183 013 patients in units assigned

46 Resistance to chlorhexidine, an antiseptic widely used to combat A. ba

47 th the sole characterized substrate of AceI, chlorhexidine, an entirely synthetic biocide produced on

48 te was 2.86 per 1000 patient-days during the chlorhexidine and 2.90 per 1000 patient-days during the

49 Challenge of K. pneumoniae with chlorhexidine and another cationic biocide, octenidine,

50 Reduced susceptibility to chlorhexidine and carriage of qacA or qacB were rare amo

51 at plaque formation was inhibited/reduced by chlorhexidine and honey rinses.

52 Chlorhexidine and latex are not part of routine testing

53 Postdischarge MRSA decolonization with chlorhexidine and mupirocin led to a 30% lower risk of M

54 n, and decolonisation of MRSA carriers) with chlorhexidine and mupirocin, and universal decolonisatio

55 decolonization, targeted decolonization with chlorhexidine and mupirocin, or universal decolonization

56 no screening, all patients decolonised) with chlorhexidine and mupirocin.

57 ed efflux through SmvA can lead to increased chlorhexidine and octenidine tolerance.

58 2 (11.9%) patients had died in the mupirocin/chlorhexidine and placebo groups, respectively.

59 most common skin preparation wipes (alcohol, chlorhexidine and povidone iodine) and found that during

60 ditional prevention measures (oral care with chlorhexidine and selective oral decontamination).

61 e further discovered the target of action of chlorhexidine and show that it is a selective inhibitor

62 ated with either 5-fluorouracil (n = 480) or chlorhexidine and silver sulfadiazine (n = 480).

63 bacteria, and Candida were cultured from the chlorhexidine and silver sulfadiazine central venous cat

64 ated with 5-fluorouracil were noninferior to chlorhexidine and silver sulfadiazine coated central ven

65 of the 5-fluorouracil group and 0.9% of the chlorhexidine and silver sulfadiazine group.

66 ernative to catheters externally coated with chlorhexidine and silver sulfadiazine when used in criti

67 ine bathing to decolonisation with universal chlorhexidine and targeted nasal mupirocin in non-critic

68 t that boric acid could be an alternative to chlorhexidine, and it might be more favorable because bo

69 lorhexidine mouthwash, baths or showers with chlorhexidine, and nasal mupirocin for 5 days twice per

70 among 183 013 patients in units assigned to chlorhexidine, and none were reported for mupirocin.

71 oral bacteria and compare the same with 0.2% chlorhexidine; and 2) to compare antiplaque efficacy in

72 Use of chlorhexidine antisepsis seems to attenuate the effect o

73 We further determine that commonly used chlorhexidine antiseptic serves as a protective and deco

74 Evidence from Asia suggests that chlorhexidine application to the neonatal umbilical cord

75 0.0%) infants in the chlorhexidine group had chlorhexidine applied within 24 h of birth.

76 Aqueous chlorhexidine (AqCHX) has been described as a possibly b

77 Perioperative allergic reactions to chlorhexidine are often severe and easily overlooked.

78 nd promoter DNA were also observed following chlorhexidine assault.

79 ry to probe the response of AceI and AceR to chlorhexidine assault.

80 Chlorhexidine-based preparations are significantly more

81 2.1% vs. 66.2%, P = 0.003), and preoperative chlorhexidine bathing (46.1% vs. 77.6%, P < 0.001).

82 onization-treatment of all ICU patients with chlorhexidine bathing and nasal mupirocin-used a prerele

83 Decolonisation with universal chlorhexidine bathing and targeted mupirocin for MRSA ca

84 Chlorhexidine bathing did not change rates of infection-

85 Compared with soap and water bathing, chlorhexidine bathing every other day decreased the risk

86 Compared with soap and water, chlorhexidine bathing every other day decreased the risk

87 its assigned to either routine care or daily chlorhexidine bathing for all patients plus mupirocin fo

88 E Infection trial was to evaluate the use of chlorhexidine bathing in non-critical-care units, with a

89 pathogen nonspecific (global), such as daily chlorhexidine bathing of all patients in the ICU.

90 During the chlorhexidine bathing period, 55 infections occurred: 4

91 on was 5.10 cases per 1000 patient-days with chlorhexidine bathing versus 6.60 cases per 1000 patient

92 ns was 4.78 cases per 1000 patient-days with chlorhexidine bathing versus 6.60 cases per 1000 patient

93 n, 2) chlorhexidine oral hygiene program, 3) chlorhexidine bathing, 4) catheter-associated bloodstrea

94 control practices (ie, active surveillance, chlorhexidine bathing, decolonization for MRSA, and hydr

95 03), the equivalent of a 23% lower rate with chlorhexidine bathing.

96 high level of compliance to hand hygiene and chlorhexidine bathings, screening and isolation of carri

97 unty, California, we evaluated the impact of chlorhexidine baths and mupirocin on all ICU admissions

98 ation of patients in the ICU with once a day chlorhexidine baths and short-course nasal mupirocin cou

99 ation measures, including once-weekly use of chlorhexidine body wash, did not prevent overall SSTI or

100 xin plus tobramycin and nasal mupirocin plus chlorhexidine body wash.

101 twice-daily intranasal mupirocin, and daily chlorhexidine body washes.

102 nasal carriers with mupirocin together with chlorhexidine body washing reduces the incidence of S. a

103 n interrupted time series study of universal chlorhexidine body-washing combined with hand hygiene im

104 Median proportions of patients receiving chlorhexidine body-washing increased from 0% to 100% at

105 Improved hand hygiene plus unit-wide chlorhexidine body-washing reduced acquisition of antimi

106 moniae has previously been shown to adapt to chlorhexidine by increasing expression of the MFS efflux

107 ed with blood culture kits containing either chlorhexidine (CH) or iodine tincture (IT) for skin anti

108 Chlorhexidine (CHG) bathing decreases incidence of blood

109 Chlorhexidine (CHG) bathing decreases the incidence of b

110 s: standard (S), enhanced standard (ES), and chlorhexidine (CHG).

111 d bi-weekly supragingival plaque removal and chlorhexidine chips application (ChxC group) for 12 week

112 ival plaque removal and local application of chlorhexidine chips had greater mean IPD reduction and g

113 n protocols (12 S/R per group): 24% EDTA, 2% chlorhexidine (CHL), gauze soaked in 2% chlorhexidine (G

114 nd antibiofilm efficiency were compared with chlorhexidine (CHX) and sodium hypochlorite (NaOCl).

115 s, the systemic use of azithromycin (AZ) and chlorhexidine (CHX) as adjuvants to non-surgical periodo

116 sites releasing antibacterial agents such as chlorhexidine (CHX) have shown biofilm-inhibitory effica

117 this study is to determine the influence of chlorhexidine (CHX) intracanal medicament on the clinica

118 Chlorhexidine (CHX) is a widely utilized disinfectant th

119 n we investigated the effect of 7-day use of chlorhexidine (CHX) mouthwash on the salivary microbiome

120 ) group II, TRP mouthwash; and 3) group III, chlorhexidine (CHX) mouthwash.

121 bstantivity of a single mouthrinse with 0.2% chlorhexidine (CHX) on saliva and on undisturbed de novo

122 olution (10(9) beads/mL) and, second, a 0.2% chlorhexidine (CHX) or 0.085% cetylpyridinium chloride (

123 available mouthwashes that contained either chlorhexidine (CHX) or essential oils (EO) as the active

124 t was suggested that periodontal therapy and chlorhexidine (CHX) rinse could affect nitrite levels, l

125 lication of local chemical adjuncts, such as chlorhexidine (CHX), have been used to control and treat

126 ecause standard adjuvant antiseptics, namely chlorhexidine (CHX), prove damaging for osteoblasts.

127 : povidone-iodine (PovI; 0.05%, 1%, and 5%), chlorhexidine (CHX; 0.2% and 1%), and sodium hypochlorit

128 Protocol included chlorhexidine cleansing of the perineum and proximal 6 i

129 c defined as a relevant clinical reaction to chlorhexidine combined with two or more positive tests.

130 eductions previously reported in south Asia, chlorhexidine cord applications did not significantly re

131 Chlorhexidine cord applications do not seem to provide c

132 r patients bathed with soap and water versus chlorhexidine, counts of incident hospital-acquired infe

133 in the units: chlorhexidine "scrub-the-hub," chlorhexidine daily baths, and daily nursing rounds aime

134 ventions, especially after implementation of chlorhexidine daily baths.

135 Transport assays using [(14)C]-chlorhexidine determined that AceI was able to mediate t

136 ions at screening) to test the efficacy of a chlorhexidine diacetate 10% weight per volume (w/v) dent

137 iller, and the ratios of calcium fluoride to chlorhexidine diacetate were 8/2, 5/5, and 2/8.

138 In this pragmatic trial, daily bathing with chlorhexidine did not reduce the incidence of health car

139 onic antifungal drugs such as miconazole and chlorhexidine digluconate (CG) through ionic interaction

140 ence rate, 80% [12 of 15 isolates]) than for chlorhexidine digluconate (median growth grade, 1.0; kil

141 whether polyhexamethylene biguanide, 0.02%, chlorhexidine digluconate, 0.02%, hexamidine diisethioon

142 -mouth SRP using 0.9% sodium chloride, 0.12% chlorhexidine digluconate, or 7.5% povidone-iodine for s

143 ensive local antiseptic interventions with a chlorhexidine disc and hypochlorite solution reduce bact

144 Antisepsis drain care included (1) a chlorhexidine disc at the drain exit site and (2) irriga

145 The combination of erythritol and chlorhexidine displayed stronger antimicrobial and antib

146 hours or more in 12 French ICUs, we compared chlorhexidine dressings, highly adhesive dressings, and

147 With chlorhexidine dressings, the major-CRI rate was 67% lowe

148 ata are consistent with AceI being an active chlorhexidine efflux protein and the founding member of

149 protein of this family, AceI (Acinetobacter chlorhexidine efflux protein I), is encoded for by the a

150 anscriptional control of AceR (Acinetobacter chlorhexidine efflux protein regulator), a LysR-type tra

151 Patients were randomized to bathing with 2% chlorhexidine every other day alternating with soap and

152 forms dimers at high pH, and that binding to chlorhexidine facilitates the functional form of the pro

153 LTP3-plasma treatment for 3 minute, CHX-0.2% chlorhexidine for 1 minute, GAS-gas only (no plasma) for

154 nts were randomly assigned to either 4% free chlorhexidine for cord care or to dry cord care using a

155 Greater use of chlorhexidine for disease prevention warrants surveillan

156 Our findings do not support the use of chlorhexidine for reduction of neonatal mortality in thi

157 to two topical microbiocides, mupirocin and chlorhexidine, frequently used for decolonization and in

158 Different chemicals (i.e., chlorhexidine, galardin, and benzalkonium chloride) or c

159 , 2% chlorhexidine (CHL), gauze soaked in 2% chlorhexidine (GCHL), gauze soaked in ultrapure water (G

160 e, consisting of head-of-bed elevation, oral chlorhexidine gel, sedation holds, and a weaning protoco

161 A large randomized trial demonstrated that chlorhexidine-gel-impregnated dressings decreased the CR

162 by repetitive intraperitoneal injections of chlorhexidine gluconate (CG) in mice with type I pro-col

163 ution of peritoneal MCs to myofibroblasts in chlorhexidine gluconate (CG)-induced fibrosis compared w

164 e collected and tested for susceptibility to chlorhexidine gluconate (CHG) by microtiter dilution; mu

165 ctive was to assess whether daily bathing in chlorhexidine gluconate (CHG) compared with standard bat

166 very of multispecies oral biofilms following chlorhexidine gluconate (CHX) and CHX with surface modif

167 films is investigated following treatment by chlorhexidine gluconate (CHX), iodine-potassium iodide (

168 is study compared the safety and efficacy of chlorhexidine gluconate 2.5 mg chip (CHX chips) as an ad

169 Patients rinsed with 0.12% chlorhexidine gluconate after debridement, and twice dai

170 ze antiseptic skin surface concentrations of chlorhexidine gluconate applied during preoperative show

171 Other intervention components such as daily chlorhexidine gluconate bathing of all patients and hand

172 s; geographic and personnel cohorting; daily chlorhexidine gluconate baths; dedicating equipment to b

173 The mean (SD) composite chlorhexidine gluconate concentrations were significantl

174 ion have assessed the safety and efficacy of chlorhexidine gluconate for cutaneous antisepsis and sil

175 Although chlorhexidine gluconate is a known cause of contact derm

176 the use of an ultrasonic unit, and that 0.2% chlorhexidine gluconate is more effective than herbal mo

177 The chlorhexidine gluconate rinse had the lowest MICs compar

178 surface (16.5 microg/cm2) concentrations of chlorhexidine gluconate that are sufficient to inhibit o

179 Chlorhexidine gluconate was used for FMD.

180 preoperative decontamination protocol using chlorhexidine gluconate washcloths and intranasal antise

181 Skin surface concentrations of chlorhexidine gluconate were analyzed using colorimetric

182 Volunteers used 118 mL of chlorhexidine gluconate, 4%, for each shower.

183 ower regimen that includes 118 mL of aqueous chlorhexidine gluconate, 4%, per shower; a minimum of 2

184 r administering the preadmission shower with chlorhexidine gluconate, 4%, resulting in maximal, persi

185 The volunteers were randomized to 2 chlorhexidine gluconate, 4%, showering groups (2 vs 3 sh

186 Preadmission showers using chlorhexidine gluconate, 4%.

187 is by delineating a precise dose (volume) of chlorhexidine gluconate, 4%; duration (number of showers

188 le preprocedural mouthrinses containing 0.2% chlorhexidine gluconate, an herbal mouthwash, and water

189 nd C) of eight patients each to receive 0.2% chlorhexidine gluconate, herbal mouthwash, and water, re

190 nhibitory effects of three test agents, 0.2% chlorhexidine gluconate, honey mouthwash, and saline, ag

191 The safety and efficacy of chlorhexidine gluconate, silver alginate, and antibiotic

192 lesions resolved with discontinuation of the chlorhexidine gluconate-containing dressings, local woun

193 Chlorhexidine gluconate-impregnated dressings have becom

194 e phenotypic range of this adverse effect of chlorhexidine gluconate-impregnated dressings in critica

195 titis is an under-recognized complication of chlorhexidine gluconate-impregnated dressings.

196 f erosive irritant contact dermatitis due to chlorhexidine gluconate-impregnated transparent dressing

197 In the chlorhexidine gluconate-induced peritoneal fibrosis mode

198 ion antiseptic skin cleansing protocol using chlorhexidine gluconate.

199 nd weekly bathing of babies >=1.5 kg with 2% chlorhexidine gluconate.

200 ingle rooms; bathing all patients daily with chlorhexidine gluconate; and healthcare-worker education

201 No difference was observed between the chlorhexidine- gluconate-impregnated sponge group and th

202 ily for up to 5 days and to bathe daily with chlorhexidine-gluconate (CHG) for up to 5 days before th

203 r (standard group), a standard catheter plus chlorhexidine-gluconate-impregnated sponge (chlorhexidin

204 chlorhexidine-gluconate-impregnated sponge (chlorhexidine-gluconate-impregnated sponge group), or an

205 ients, 156 in the standard-group, 150 in the chlorhexidine-gluconate-impregnated sponge group, and 15

206 (15.4%) standard catheters, 21 (14%) in the chlorhexidine-gluconate-impregnated sponge group, and 25

207 e (5.8%) standard catheters, six (4%) in the chlorhexidine-gluconate-impregnated sponge group, and se

208 Mortality rate in the chlorhexidine group (10.5 deaths per 1000 livebirths) wa

209 rence in neonatal mortality rate between the chlorhexidine group (15.2 deaths per 1000 livebirths) an

210 births, 18 450 (99.7%) newborn babies in the chlorhexidine group and 19 308 (99.8%) newborn babies in

211 16 660 (90.0%) infants in the chlorhexidine group had chlorhexidine applied within 24

212 17 468 (96.9%) of 18 015 neonates in the chlorhexidine group were available for complete follow-u

213 For babies allocated to the chlorhexidine group, mothers or caretakers were advised

214 eriodontitis (e.g., scaling/root planing and chlorhexidine) have limited efficacy since they fail to

215 ClinicalTrials.gov website: povidone-iodine, chlorhexidine, hydrogen peroxide, cyclodextrin, Citrox,

216 Chlorhexidine-impregnated and strongly adherent dressing

217 were assigned to intranasal mupirocin and 2% chlorhexidine-impregnated cloths (active treatment, n =

218 eus, treatment with intranasal mupirocin and chlorhexidine-impregnated cloths compared with placebo s

219 olonization was also markedly reduced in the chlorhexidine-impregnated dressing group (random effects

220 Our analysis shows that a chlorhexidine-impregnated dressing is beneficial in prev

221 Use of a chlorhexidine-impregnated dressing resulted in a reduced

222 lar and femoral was suppressed by the use of chlorhexidine-impregnated dressings.

223 catheter-related infections and the costs of chlorhexidine-impregnated sponge and contact dermatitis

224 ssing cost $9.08 (146 observations) and each chlorhexidine-impregnated sponge cost $9.73.

225 atients, 28,931 catheter days) showed that a chlorhexidine-impregnated sponge decreased the incidence

226 ge use saved $197 per patient with the 3-day chlorhexidine-impregnated sponge dressing change strateg

227 Chlorhexidine-impregnated sponge for arterial and centra

228 Chlorhexidine-impregnated sponge use remained cost savin

229 incidence of 1.4 per thousand catheter days, chlorhexidine-impregnated sponge use saved $197 per pati

230 Here, we assessed the cost benefits of chlorhexidine-impregnated sponge use.

231 ce of multiresistant Gram-negative bacteria, chlorhexidine-impregnated sponges and Oligon catheters a

232 to evaluate the effect of daily bathing with chlorhexidine-impregnated washcloths on the acquisition

233 ed to bathe patients either with no-rinse 2% chlorhexidine-impregnated washcloths or with nonantimicr

234 Daily bathing with chlorhexidine-impregnated washcloths significantly reduc

235 washcloths (P=0.007), a 28% lower rate with chlorhexidine-impregnated washcloths.

236 e hypothesized that the ratio of fluoride to chlorhexidine incorporated into a resin, and the pH of t

237 ch lacks a homologue to SmvAR, resistance to chlorhexidine increased (4-fold) but plasmid carriage of

238 ps: 1) SRP + saline irrigation (C); 2) SRP + chlorhexidine irrigation (CHX); and 3) SRP + boric acid

239 ogic parameters and compare this method with chlorhexidine irrigation and SRP alone in patients with

240 new formulation consisting of erythritol and chlorhexidine is compared with the standard glycine powd

241 broad-spectrum, topical antimicrobial agent chlorhexidine is widely performed and may reduce health

242 Chlorhexidine is widely used as an antiseptic or disinfe

243 Aqueous chlorhexidine may be a better tolerated alternative to P

244 Chlorhexidine may compromise the biocompatibility of tit

245 suggest that daily bathing of patients with chlorhexidine may prevent hospital-acquired bloodstream

246 tion drainage endotracheal tubes, oral care, chlorhexidine mouth care, and daily spontaneous awakenin

247 with BRONJ were using antibiotics (48%) or a chlorhexidine mouthrinse (84%) at enrollment.

248 ygiene measures and were advised to use 0.2% chlorhexidine mouthwash for 1 week before being allocate

249 nical therapy and its association with 0.12% chlorhexidine mouthwash reduced peri-implant mucositis.

250 Decolonization involved chlorhexidine mouthwash, baths or showers with chlorhexi

251 AB, along with standard care debridement and chlorhexidine mouthwash.

252 36 911 newborn babies were enrolled into the chlorhexidine (n=18 015) and dry cord care study (n=18 8

253 density and the antimicrobial mechanisms for chlorhexidine, nano-silver, quaternary ammonium methacry

254 f a synergistic effect with the bisguanidine chlorhexidine on cell membrane disruption has been obser

255 s with disposable cloths impregnated with 2% chlorhexidine or nonantimicrobial cloths as a control.

256 rogram with refresher education campaign, 2) chlorhexidine oral hygiene program, 3) chlorhexidine bat

257 257) received scaling and root planing plus chlorhexidine oral rinse at baseline and supportive peri

258 cluding manual tooth/gum brushing plus 0.12% chlorhexidine oral rinse, twice per day, plus upright po

259 nd in the saline-treated group compared with chlorhexidine (P = 0.03).

260 were similar (18.9% soap and water vs 18.6% chlorhexidine; p = 0.95).

261 and air polished with glycine or erythritol-chlorhexidine powders.

262 pedic, 61 vascular, and 56 other), mupirocin/chlorhexidine reduced 1-year mortality: 11 of 365 (3.0%)

263 harynx and the gastric tube plus a mupirocin/chlorhexidine regimen in intubated patients and standard

264 Chlorhexidine release was sustained for almost 2 months

265 e of fluoride salt substantially reduced the chlorhexidine release, while the presence of a specific

266 d acidic residue, although unable to mediate chlorhexidine resistance and transport, was still able t

267 ii, to chlorhexidine to identify the primary chlorhexidine resistance elements.

268 e isolates, with no evidence of mupirocin or chlorhexidine resistance.

269 of the regulator SmvR, through adaptation to chlorhexidine, results in increased resistance to a numb

270 Group differences in antibiotics and chlorhexidine rinse usage may have masked differences in

271 n rates after the stepwise implementation of chlorhexidine "scrub-the-hub" and daily baths in surgica

272 implemented at different times in the units: chlorhexidine "scrub-the-hub," chlorhexidine daily baths

273 Air polishing with erythritol-chlorhexidine seems to be a viable alternative to the tr

274 while the presence of a specific quantity of chlorhexidine significantly increased fluoride release.

275 uorouracil (RR, 0.34 [95% CI, .14-.82]), and chlorhexidine-silver sulfadiazine (RR, 0.60 [95% CI, .50

276 which included a preoperative shower with 4% chlorhexidine soap, appropriate hair removal, adequate p

277 e effect of umbilical cord cleansing with 4% chlorhexidine solution on neonatal mortality and omphali

278 rol) or topical application of 10 mL of a 4% chlorhexidine solution once per day until 3 days after c

279 an those of free TVO, TVO nanoemulsions, and chlorhexidine solutions against E. coli and S. aureus.

280 he next most highly overexpressed gene under chlorhexidine stress was annotated as encoding a hypothe

281 We describe the selection of reduced chlorhexidine susceptibility during chlorhexidine use in

282 human pathogen, Acinetobacter baumannii, to chlorhexidine to identify the primary chlorhexidine resi

283 Addition of 2-mg/mL chlorhexidine to the buffer solution resulted in the inh

284 low, and compared to sterile, untreated and Chlorhexidine-treated controls.

285 Chlorhexidine umbilical cord washes reduce neonatal mort

286 reduced chlorhexidine susceptibility during chlorhexidine use in a patient with two episodes of cuta

287 ng semirecumbent positioning, oral care with chlorhexidine, venous thromboembolism prophylaxis, stres

288 lity: 11 of 365 (3.0%) died in the mupirocin/chlorhexidine versus 21 of 301 (7.0%) in the placebo gro

289 ring blood culture contamination rates using chlorhexidine versus iodine tincture for skin antisepsis

290 -related bloodstream infection (CR-BSI) with chlorhexidine versus nonchlorhexidine dressings and cath

291 Aqueous chlorhexidine was associated with a low rate of postinje

292 xin/tobramycin/amphotericin B plus mupirocin/chlorhexidine was associated with the reduction of all-c

293 FU counts (P < 0.01 versus control), whereas Chlorhexidine was least effective; biofilm imaging resul

294 Therefore, 0.12% of chlorhexidine was not more effective than placebo.

295 Chlorhexidine was well tolerated, and only 1 patient wit

296 that preoperative MRSA decontamination with chlorhexidine washcloths and oral rinse and intranasal p

297 eo about MRSA decontamination and were given chlorhexidine washcloths and oral rinse and nasal povido

298 ientific, Philadelphia, Pa) and a regimen of chlorhexidine washes were prescribed.

299 ions, mechanical and oral bowel preparation, chlorhexidine washes, and carbohydrate drink to all pati

300 We compared the effect of chlorhexidine with dry cord care on neonatal mortality r

301 est group (basic periodontal therapy + 0.12% chlorhexidine) with 61 implants; and control group (basi